110 likes | 433 Vues
Corneal Infections in the setting of Epithelial Basement Membrane Dystrophy.
E N D
Corneal Infections in the setting of Epithelial Basement Membrane Dystrophy Melissa B DaluvoyMD, NeelofarGhaznawi MD, Kristin M Hammersmith MD, Edwin S Chen MD, Christopher J Rapuano MD, Elisabeth J Cohen MDCornea Service, Wills Eye Institute, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA The authors have no financial interest in the subject matter of this poster
Introduction: • Epithelial basement membrane dystrophy (EBMD) is the most common anterior corneal dystrophy. • Histopathologically , the epithelial basement membrane has poorly functioning adhesion complexes leading to a weak attachment of epithelium to Bowman’s membrane; making these corneas more susceptible to spontaneous or recurrent erosions (RES)1. • Any break in the epithelium can predispose a cornea to microbial infection. • One study of corneal infections (n=1786) reported 0.6% were secondary to RES2. In our experience EBMD is a small, but real, risk for infectious keratitis.
Clinical photograph of a patient with epithelial basement dystrophy Courtesy of Edwin S. Chen, MD Histopathology of degenerated epithelial cells trapped in abnormal epithelium; presents clinically as a microcyst. Courtesy of Ralph Eagle, MD
Purpose: To describe infectious keratitis due to underlying hereditary EBMD and EBM changes from previous trauma.
Methods: • We performed a retrospective chart review of patients with infectious keratitis secondary to EBMD from 1/1/2007 to 9/30/2009 at a tertiary care center. • Patients with recent trauma, bullouskeratopathy, or contact lens wear were excluded. • Laterality of EBMD changes, history of remote trauma, RES, and social, medical and ocular history were recorded. • The active treatment for the keratitis, duration of follow-up and time to resolution, vision as well as culture results and complications were also noted.
Results: • Thirteen patients were identified. • All patients were referred for consultation after onset of infection and initiation of some form of treatment. • Average age at onset of the infection was 61.6 +/-12.8 years; 61.5% were female. • All cases had unilateral infections; 61.5% were of the right eye. • 92.3% had EBMD in both eyes • 23.1% had reported history of remote trauma in the affected eye • 46.2% had reported history of RES in the affected eye. • Clinical findings on presentation included infiltrate (100%), epithelial defect(85%), hypopyon(23%), and stromal edema(69%). • All were treated with topical antibiotics • 8 (61.5%) were cultured: 5 (62.5%) of those were positive • 6 (46.2%) patients were started on fortified antibiotics/antifungals on their 1st visit. • Pathogens included S. aureus, S. epidermidis, P. aeruginosa, MRSA, and Candida. • One patient was hospitalized and treated for corneal perforation.
Previous studies: culture results3-8 3 cultured; all were pos: Pseudomonas; S. aureus (2) 2 cultured = all neg 11 cultured = S. aureus (2) 1 cultured = all neg 5 cultured = all neg
Conclusion: • EBMD is known to cause considerable morbidity including ocular pain, RES and decreased vision8. • Infectious keratitis is a vision threatening complication that can lead to scarring and perforation. • Our series had a 62.5% culture positivity rate with a wide variety of organisms. • Given the serious ocular morbidity associated with infectious keratitis we recommend intense antimicrobial treatment as first line therapy. • When counseling patients regarding the prognosis and treatment of EBMD or faced with an ulcer of unknown etiology, ophthalmologists should consider the possibility of infectious complications caused by EBMD.
References: • Anterior Segment The Requisits. Rapuano, Luchs, Kim. Mosby, 2000. • Ibrahim YW, Boase DL, Cree IA. Epidemiological characteristics, predisposing factors and microbial profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol. 2009;93:1319-1324. • Schoch DE, Stock EL, Schwartz, AE. Stromal keratitis complicating anterior membrane dystrophy. Am J Ophthalmol. 1985;100:199-201. • Jaros PA, DeLuise VP. Stromal keratitis with anterior membrane dystrophy. Ann Ophthalmol. 1986;18: 283-284. • Ionides ACW, Tuft SJ, Ferguson VMG, Matheson MM, Hykin PG. Corneal infiltration after recurrent conreal epithelial erosion. Br. J Ophthalmol. 1997; 81:537-540. • Tabery HM. Corneal stromal infiltrates in patients with recurrent erosions. ActaOphthalmol. Scand. 1998;76:589-592. • McElvanney AM. Hypopyon keratitis in corneal epithelial basement membrane dystrophy. Eye. 1999; 13:585-586. • Trobe, JD, Laibson PR. Dystrophic changes in the anterior cornea. Arch Ophthal. 1972; 87:378-382. • Hykin PG, Foss AE, Pavesio C, Dart JK. The natural history and mangement of recurrent corneal erosion: a prospective randomised trial. Eye (London). 1994;8:35-40. • Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea. Cornea. 2000;19(6):767-771.